(Date:11/24/2009)..., , ST. LOUIS, Nov. 24 /PRNewswire-First...) will be presenting at the NASDAQ OMX conference ... 7:45 AM US/CST. Interested parties may listen via...at http://inve s tor.sig m a a ldrich.com/...this file. ,, About Sigma-Aldrich: Sigma-...
(Date:11/24/2009)..., , SHANGHAI, Nov. 24 /PRNewswire-...ate Food & Drug Administration (SFDA) has appr...) for its oral insulin project,(Nodlin), an innova...ND,approval allows Biolaxy to initiate its first p...sorder characteristic of high blood glucose and po...
(Date:11/24/2009)..., , DUBLIN, November 24 /PRNewswire-Fi... the global specialty biopharmaceutical company, t...European Medicines Agency for,velaglucerase alfa, ...pment,for the treatment of Type 1 Gaucher disease....lucerase alfa that has been submitted, with previo...
(Date:11/24/2009)... Chemical Abstracts Servic..., reports that China,s patent office is now the wo...tions in chemistry. China trailed Japan,s patent o...n (WIPO), and the United States Patent and Tradema...ed the USPTO in 2005, WIPO in 2006, and exceeded J...
Breaking Biology Technology:Biolaxy Secures IND Approval for Oral Insulin 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 3Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 4China Leads All Nations in Publication of Chemical Patents According to CAS, the World's Most Authoritative Publisher of Chemical Information 2China Leads All Nations in Publication of Chemical Patents According to CAS, the World's Most Authoritative Publisher of Chemical Information 3...(Nasdaq: VRUS ) management will present at the 3r...2008, at the Citi Executive Conference Center, New...gan Stanley Global,Healthcare Unplugged Conference...ew York, NY. Schaefer Price, Pharmasset,s Chief Ex...he company followed by a question and,answer sessi...
...ESMO Congress,in Stockholm, the premier European c... medical oncologists, as well as a focal point to ...nes., The Congress Centre will be the venue for i...nd a place to discuss critical issues for,European...raining of young,oncologists and better integratio...
...rstCall/ -- Huifeng Bio-,Pharmaceutical Technology... leading developer and producer of plant extracts ...ceutical, nutraceutical and food production in,Xi,...nt to enter into a,contractual arrangement with Xi...e proposed terms of this arrangement, Huifeng will...
Other Biology Technology:Pharmasset to Present at the Upcoming Citibank and Morgan Stanley Investor Conferences 233rd ESMO Congress in Stockholm, 12-16 September 2008 233rd ESMO Congress in Stockholm, 12-16 September 2008 333rd ESMO Congress in Stockholm, 12-16 September 2008 433rd ESMO Congress in Stockholm, 12-16 September 2008 5Huifeng Bio-Pharmaceutical (HFGB) Enters into Letter of Intent with Xi'an Qinba Xintong Medical Ltd. 2Silencer Pre-designed siRNA, PAGE purified, annealed from Ambion
Custom siRNA, standard purity, annealed from Ambion
...ed to rapidly and reliably amplify unknown genomic...rovides hassle-free, ready-to use components, at a... ingredients are provided in each kit. The Genome ... cloning of genomic DNA, isolating promoter and re...
Bis-acrylamide, Ultra Pure from Research Organics, Inc.
Biology Products: